Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2266977 Title: Composés de 2,4-di[(hétéro)arylamino]pyrimidine comme inhibiteurs de la zap-70 et/ou syk kinase

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
101782910
WO application number:
Type:
European patent granted for BE
Status:
Deemed Void
Publication number:
2266977
WO publication number:
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
15/09/2004
Grant date:
14/05/2014
EP publication date:
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
14/05/2014
EP B1 publication date:
14/05/2014
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
15/09/2024

Applicant

1

Name:
Novartis AG
Legal Form:
From:
14/05/2014
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)
To:

2

Name:
Novartis Pharma GmbH
Legal Form:
From:
14/05/2014
Address:
Brunner Strasse 59, 1230, Wien, Austria (AT)
To:

Inventor

1

Name:
Baenteli, Rolf
Legal Form:
Address:

2

Name:
Bernhard, Marie
Legal Form:
Address:

3

Name:
Buehlmayer, Peter
Legal Form:
Address:

4

Name:
Cooke, Nigel
Legal Form:
Address:

5

Name:
Duthaler, Rudolf
Legal Form:
Address:

6

Name:
Hinterding, Klaus
Legal Form:
Address:

7

Name:
Thoma, Gebhard
Legal Form:
Address:

8

Name:
Van Eis, Maurice
Legal Form:
Address:

9

Name:
Von Matt, Anette
Legal Form:
Address:

10

Name:
Walliser, Louis
Legal Form:
Address:

11

Name:
Zenke, Gerhard
Legal Form:
Address:

Priority

1

Priority patent number:
0321710
Priority date:
16/09/2003
Priority country:
United Kingdom (GB)

2

Priority patent number:
0414440
Priority date:
28/06/2004
Priority country:
United Kingdom (GB)

Classification

Main IPC class:
C07D 405/12;
IPC or IDT classification:
C07D 239/48; C07D 405/14; C07D 413/14; C07D 417/14; C07D 403/12; A61K 31/506;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2014/05
Publication date:
16/08/0016
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

Annual fee

Annual fee(s) Due Date:
30/03/2015
Annual fee number:
11
Annual fee amount:
195 Euro
Penalty fee amount:
210 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type